Arzeda Patents – Insights & Stats (Updated 2023)

Arzeda has a total of 39 patents globally, out of which 15 have been granted. Of these 39 patents, more than 71% patents are active. United States of America is where Arzeda has filed the maximum number of patents, followed by Australia and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Arzeda.

Arzeda was founded in the year 2009. The Company develops enzyme design technology in the United States.

Do read about some of the most popular patents of Arzeda which have been covered by us in this article and also you can find Arzeda patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Arzeda patent portfolio.

How many patents does the founder and the CEO of Arzeda have?

The founder and CEO Alexandre Zanghellini has 28 patents.

How many patents does Arzeda have?

Arzeda has a total of 39 patents globally. These patents belong to 9 unique patent families. Out of 39 patents, 28 patents are active.

How Many Patents did Arzeda File Every Year?

Arzeda Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantArzeda Applications FiledArzeda Patents Granted
20231
202231
202132
202033
201962
201821
20172
201623
20148
20131
201111

How many Arzeda patents are Alive/Dead?

Arzeda Patent Portfolio

 How Many Patents did Arzeda File in Different Countries?

Arzeda Worldwide Patent Filing

Countries in which Arzeda Filed Patents

CountryPatents
United States Of America10
Australia5
Canada4
Europe4
Brazil3
Russia2
China2
India2
Japan1
Mexico1

Where are Research Centres of Arzeda Patents Located?

The Research Centre for all the Arzeda patents is the United States of America.

What Percentage of Arzeda US Patent Applications were Granted?

Arzeda (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 5 have been granted leading to a grant rate of 62.5%.

Below are the key stats of Arzeda patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Arzeda?

Law FirmTotal ApplicationsSuccess Rate
Cooley6100.00%
Dupont Pioneer30.00%

List of Arzeda Patents

Arzeda PatentsTitle
US11393556B2Automated Method Of Computational Enzyme Identification And Design
US11060119B2Methods And Compositions For Preparing Tagatose From Fructose
US10246727B2Fermentation Route For The Production Of Levulinic Acid, Levulinate Esters And Valerolactone And Derivatives Thereof
US10025900B2Automated Method Of Computational Enzyme Identification And Design
US9523105B2Fermentation Route For The Production Of Levulinic Acid, Levulinate Esters And Valerolactone And Derivatives Thereof
US20230045710A1Automated Method Of Computational Enzyme Identification And Design
US20220228186A1Compositions And Methods For Producing Steviol Glycosides
US20220025413A1Methods And Compositions For Preparing Tagatose From Fructose
EP3818156A4Methods And Compositions For Preparing Tagatose From Fructose
EP3973069A1Compositions And Methods For Producing Steviol Glycosides
EP2611764A4Fermentation Route For The Production Of Levulinic Acid, Levulinate Esters, Valerolactone, And Derivatives Thereof
CN107098807BFermentative Pathways For The Production Of Levulinic Acid, Levulinate Esters, Valerolactone, And Their Derivatives
CN103180279BFermentation Pathways For The Production Of Levulinic Acid, Levulinic Acid Esters, Valerolactones, And Derivatives Thereof
WO2022178145A1Compositions And Methods For Producing Rebaudioside D
AU2018201168B2Fermentation Route For The Production Of Levulinic Acid, Levulinate Esters, Valerolactone, And Derivatives Thereof
AU2016206395B2Fermentation Route For The Production Of Levulinic Acid, Levulinate Esters, Valerolactone, And Derivatives Thereof
AU2011296103B2Fermentation Route For The Production Of Levulinic Acid, Levulinate Esters, Valerolactone, And Derivatives Thereof
AU2019297508A1Methods And Compositions For Preparing Tagatose From Fructose
CA2845697CFermentation Route For The Production Of Levulinic Acid, Levulinate Esters, Valerolactone, And Derivatives Thereof
CA3208720A1Compositions And Methods For Producing Rebaudioside D
CA3105219A1Methods And Compositions For Preparing Tagatose From Fructose
BR112013004868B1Method For Producing 2,4-Dihydroxypentanoic Acid And Method For Producing A Polymeric Material Or Polymer-Containing Product
BR112021000015A2Methods And Compositions For Preparing Fructose Tagatose
IN330380BFermentation Route For The Production Of Levulinic Acid Levulinate Esters Valerolactone And Derivatives Thereof
RU2784878C9Method For Production Of 2-Oxo-4-Valerolactone
RU2634120C2Enzyme Producing Of Levulinic Acid, Levulinate Complex Esters, Valerolactone And Their Derivatives
IN202117004264AMethods And Compositions For Preparing Tagatose From Fructose
MX2021000066AMethods And Compositions For Preparing Tagatose From Fructose.
US20160040149A1Compositions Having Dicamba Decarboxylase Activity And Methods Of Use
US20140287419A1Compositions Having Dicamba Decarboxylase Activity And Methods Of Use
EP2970935A1Compositions Having Dicamba Decarboxylase Activity And Methods Of Use
WO2020237226A1Compositions And Methods For Producing Steviol Glycosides
WO2020010260A9Methods And Compositions For Preparing Tagatose From Fructose
WO2014153242A9Compositions Having Dicamba Decarboxylase Activity And Methods Of Use
WO2012030860A1Fermentation Route For The Production Of Levulinic Acid, Levulinate Esters, Valerolactone, And Derivatives Thereof
AU2014236162A1Compositions Having Dicamba Decarboxylase Activity And Methods Of Use
CA2904537A1Compositions Having Dicamba Decarboxylase Activity And Methods Of Use
BR112015023286A2Recombinant Polypeptide With Dicamamba Decarboxylase Activity, Polynucleotide Construct, Cell, Method Of Production Of A Host Cell Comprising A Polynucleotide Heterologist That Encodes A Polypeptide Activity With Dicambamba Activity Decarboxylase, A Dicambamba Decarboxylary Method, A Dicambamba Derivative Or A Dicambamba Metabolite, Method For The Detection Of A Polypeptide And Method For The Detection Of The Presence Of A Polynucleotide Encoding A Polypeptide Having Dicamba Decarboxylase Activity
JP2013538060AFermentative Pathways For The Production Of Levulinic Acid, Levulinic Acid Esters, Valerolactone, And Their Derivatives

What are Arzeda key innovation segments?

What Technologies are Covered by Arzeda?

The chart below distributes patents filed by Arzeda in different countries on the basis of the technology protected in patents. It also represents the markets where Arzeda thinks it’s important to protect particular technology inventions.

R&D Focus: How has Arzeda search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Arzeda?

Table of Content

Insights you may find interesting

Related Articles

Normet Patents – Insights & Stats (Updated 2024)

Normet has a total of 164 patents globally, out of which 121 have been granted. Of these 164 patents, more than 87% patents are active. Europe (EPO) is where Normet has filed the maximum number of patents, followed by Australia and Canada. Parallelly, Finland seems to be the main focused

Read More »

Hive Box Patents – Insights & Stats (Updated 2024)

Hive Box has a total of 733 patents globally, out of which 448 have been granted. Of these 733 patents, more than 63% patents are active. China is where Hive Box has filed the maximum number of patents, followed by Korea (South). Parallelly, China seems to be the main focused

Read More »

Greensill Patents – Insights & Stats (Updated 2024)

Greensill has a total of 38 patents globally, out of which all the patents have been granted. Of these 38 patents, all the patents are active. Europe (EPO) and United Kingdom is where Greensill has filed the maximum number of patents. Parallelly, Europe (EPO) seems to be the main focused

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.